NUVISAN The Science CRO
Charlotte Kopitz is currently serving as the EVP and Head of Therapeutic Research at Nuvisan Pharma Services Group since July 2020. Prior to this role, Charlotte spent over a decade at Bayer Pharmaceuticals, where Charlotte held various positions including Head of Therapeutic Research ICB and Senior Scientist. Before their industry roles, Charlotte worked as a PostDoc at Klinikum Rechts Der Isar. Charlotte holds a Dr. rer. nat. from the Technical University of Munich and a Dipl. Biol. in Biologie from Freie Universität Berlin.
This person is not in any teams
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.